Citation

BibTex format

@article{Prabhakar:2026:10.1172/JCI199159,
author = {Prabhakar, A and De, Bie EM and DesJardin, JT and Ghatpande, P and Gräf, S and Howard, LS and Wort, SJ and Church, C and Kiely, DG and UK, Pulmonary Arterial Hypertension Cohort Study Consortium and Sumpena, E and Aung, T and Carter, S and Kukreja, J and Hays, S and Greenland, JR and Singer, JP and Wax, M and Wolters, PJ and Simon, MA and Toshner, M and Lagna, G and Hata, A},
doi = {10.1172/JCI199159},
journal = {J Clin Invest},
title = {GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension.},
url = {http://dx.doi.org/10.1172/JCI199159},
volume = {136},
year = {2026}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Study identifies GDF15 as a biomarker-accurately distinguishing PVOD from other PAH forms and predicting outcomes across PVOD, IPAH, and HPAH-advancing earlier diagnosis and personalized treatment.
AU  - Prabhakar,A
AU  - De,Bie EM
AU  - DesJardin,JT
AU  - Ghatpande,P
AU  - Gräf,S
AU  - Howard,LS
AU  - Wort,SJ
AU  - Church,C
AU  - Kiely,DG
AU  - UK,Pulmonary Arterial Hypertension Cohort Study Consortium
AU  - Sumpena,E
AU  - Aung,T
AU  - Carter,S
AU  - Kukreja,J
AU  - Hays,S
AU  - Greenland,JR
AU  - Singer,JP
AU  - Wax,M
AU  - Wolters,PJ
AU  - Simon,MA
AU  - Toshner,M
AU  - Lagna,G
AU  - Hata,A
DO  - 10.1172/JCI199159
PY  - 2026///
TI  - GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension.
T2  - J Clin Invest
UR  - http://dx.doi.org/10.1172/JCI199159
UR  - https://www.ncbi.nlm.nih.gov/pubmed/41264364
VL  - 136
ER  -
Download